Eikon Therapeutics
Healthcare AI
Drug discovery / biopharmaceuticals
Public
Eikon Therapeutics is a late-stage clinical biopharmaceutical company that uses a proprietary single-molecule tracking platform, live-cell super-resolution microscopy, and machine learning to discover and develop therapeutics, with an initial focus on oncology. It was founded in 2019 and operates from the San Francisco Bay Area.
Company Details
- Website
- eikontx.com
- Headquarters
- Millbrae, California, United States
- Founded
- 2019
- Funding
- ~$1.1B+
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring